Previous work on DLB brains also showed a trend in reduction of GCase activity in patients without GBA mutation, while in GBA mutations carriers the activity of the enzyme was drastically reduced with respect to control subjects [15]. This evidence concerns the gene GBA1 and Lewy body dementia.